Exclusive Summary

• Capitalize on upcoming patent cliffs in key global markets to enable "Day-1 Launch" strategies and early market entry.
• Target high-burden diseases with a gold-standard therapy, ensuring a massive and rigid patient demand globally.
• Leverage vertical integration (API + FDF) to offer superior cost competitiveness over originators and international competitors.
• Minimize regulatory risks for potential licensees through available CTD dossiers and global GMP-compliant manufacturing standards.

Asset Materials

Contact Us for Full Materials